ID: ALA5184346

Max Phase: Preclinical

Molecular Formula: C16H14N2O5S

Molecular Weight: 346.36

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1CNC(=O)N1C(=O)c2ccccc2S1(=O)=O

Standard InChI:  InChI=1S/C16H14N2O5S/c1-23-13-8-4-2-6-11(13)10-17-16(20)18-15(19)12-7-3-5-9-14(12)24(18,21)22/h2-9H,10H2,1H3,(H,17,20)

Standard InChI Key:  REOVDRBXAOLCDP-UHFFFAOYSA-N

Associated Targets(Human)

JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FBP1 Tchem Fructose-1,6-bisphosphatase (1199 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 346.36Molecular Weight (Monoisotopic): 346.0623AlogP: 1.75#Rotatable Bonds: 3
Polar Surface Area: 92.78Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.65CX Basic pKa: CX LogP: 1.89CX LogD: 1.89
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.91Np Likeness Score: -1.12

References

1. Wen W, Cao H, Xu Y, Ren Y, Rao L, Shao X, Chen H, Wu L, Liu J, Su C, Peng C, Huang Y, Wan J..  (2022)  N-Acylamino Saccharin as an Emerging Cysteine-Directed Covalent Warhead and Its Application in the Identification of Novel FBPase Inhibitors toward Glucose Reduction.,  65  (13.0): [PMID:35786925] [10.1021/acs.jmedchem.2c00336]

Source